Komori
Financial Results Presentation7061Japan Hospice Holdings Inc.Information and Communications, Services and Others

FAQ on Financial Results for the Second Quarter of the Fiscal Year Ending December 2026

The company classified its earnings forecast and year-end dividend forecast for the fiscal year ending December 2026 as "undecided," as it was unable to reasonably estimate the impact of the revisions to medical service fees. In the hospice housing business, profitability deteriorated due to lower medical insurance reimbursement per resident and a decline in the number of residents, while the company outlined 4 measures aimed at achieving monthly profitability during 2026.

Worth reading
38Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Deterioration
Direction inferred from the company’s description.
Scale
20
¥10,000s / month-on-month decline in medical insurance per resident
Wording
Avoiding a definitive answer
How definitive the wording is.

Contents of this document

Summary of Q&ASecond quarter of the fiscal year ending December 20266 items taken from the company’s own explanation
Financial Results Figures (The key points of this material are explained below)
Full-year earnings forecastUndecided (figures not disclosed)
What the company explained in this material
Key points of the Q&AKey questions raised by investors at the briefing and the company's answers
  1. Impact of the revisions to medical service fees: Medical insurance reimbursement per resident declined by approximately ¥200,000, and the number of residents fell by more than 100. The ordinary profit margin declined from +10% in May to -9% in June.
  2. Achieving profitability in the hospice housing business: The company aims to achieve monthly profitability during 2026 by optimizing housing rents and other charges, improving productivity in home-visit nursing, providing higher-value-added services, and recovering the actual utilization rate relative to staffing levels.
  3. Withdrawal of the earnings and dividend forecasts: The company classified its earnings forecast and year-end dividend forecast as undecided because it was unable to reasonably calculate the impact of the new system.
  4. Business plan from 2027 onward: The plan will be prepared after the impact of the revisions to medical service fees has been examined in detail, so the timing of its release is undecided.
  5. Impact of interest-rate hikes: Most interest expense consists of amounts calculated under lease accounting, so the impact of interest-rate hikes on earnings is limited.
  6. Partnership with Sugi Holdings: The company is focusing on raising awareness, jointly developing facilities, and improving the quality of palliative care, and has achieved 7 jointly developed facilities.
  7. Capital increase policy: The company recognizes that equity financing is unnecessary in the short term and will make a decision over the medium to long term based on market conditions and other factors.
  8. Recruitment status: Applications exceeded the number of available positions, and there has been no instance of an opening being delayed because of recruitment.
  9. Facility ownership structure: New facilities are primarily operated under lease arrangements, with approximately 90% of all facilities using this structure.
Breakdown of Factors Affecting the ChangeReasons cited by the Company for the change in the figures.
  • Decline in sales per unit due to the revisions to medical service fees and the transition to bundled home-visit nursing care feesApproximately ¥200,000 decline per resident
  • Temporary decline in price competitiveness following increases in housing rents and other chargesMore than 100 fewer residents than at the May peak
  • Decline in the ordinary profit margin of the hospice housing businessFrom +10% in May to -9% in June
New initiatives
  • Optimization of housing rents and other charges
  • Improvement of productivity in home-visit nursing
  • Provision of the Life Plan service
  • Recovery in the operating rate relative to staffing levels
  • Collaboration with Sugi Holdings on joint facility development and improving the quality of palliative care
Unit price and quantity metricsThese figures show sales broken down by price and volume.
  • Medical insurance reimbursement per residentApproximately ¥200,000 decline
  • Number of residentsMore than 100 fewer
Number of stores and locations
There are 7 jointly developed facilities in total, and approximately 10 facilities scheduled to open or currently under discussion from 2026 onward. Approximately 90% of all facilities are operated under lease arrangements. The number of facilities at period-end and the number of openings and closures were not disclosed.
Annual Dividend
The year-end dividend forecast is undecided. The interim and annual dividend amounts were not disclosed.
Contents of this document
ItemDetails
Document typeSummary of Q&A
Fiscal Period CoveredSecond quarter of the fiscal year ending December 2026
Full-year earnings forecastUndecided (figures not disclosed)
Breakdown of Factors Affecting the ChangeFactors Decline in sales per unit due to the revisions to medical service fees and the transition to bundled home-visit nursing care fees / Amount Approximately ¥200,000 decline per resident, Factors Temporary decline in price competitiveness following increases in housing rents and other charges / Amount More than 100 fewer residents than at the May peak, Factors Decline in the ordinary profit margin of the hospice housing business / Amount From +10% in May to -9% in June
Unit price and quantity metricsIndicator Medical insurance reimbursement per resident / Value Approximately ¥200,000 decline, Indicator Number of residents / Value More than 100 fewer
Number of stores and locationsThere are 7 jointly developed facilities in total, and approximately 10 facilities scheduled to open or currently under discussion from 2026 onward. Approximately 90% of all facilities are operated under lease arrangements. The number of facilities at period-end and the number of openings and closures were not disclosed.
Annual DividendThe year-end dividend forecast is undecided. The interim and annual dividend amounts were not disclosed.
Key points of the Q&AImpact of the revisions to medical service fees: Medical insurance reimbursement per resident declined by approximately ¥200,000, and the number of residents fell by more than 100. The ordinary profit margin declined from +10% in May to -9% in June., Achieving profitability in the hospice housing business: The company aims to achieve monthly profitability during 2026 by optimizing housing rents and other charges, improving productivity in home-visit nursing, providing higher-value-added services, and recovering the actual utilization rate relative to staffing levels., Withdrawal of the earnings and dividend forecasts: The company classified its earnings forecast and year-end dividend forecast as undecided because it was unable to reasonably calculate the impact of the new system., Business plan from 2027 onward: The plan will be prepared after the impact of the revisions to medical service fees has been examined in detail, so the timing of its release is undecided., Impact of interest-rate hikes: Most interest expense consists of amounts calculated under lease accounting, so the impact of interest-rate hikes on earnings is limited., Partnership with Sugi Holdings: The company is focusing on raising awareness, jointly developing facilities, and improving the quality of palliative care, and has achieved 7 jointly developed facilities., Capital increase policy: The company recognizes that equity financing is unnecessary in the short term and will make a decision over the medium to long term based on market conditions and other factors., Recruitment status: Applications exceeded the number of available positions, and there has been no instance of an opening being delayed because of recruitment., Facility ownership structure: New facilities are primarily operated under lease arrangements, with approximately 90% of all facilities using this structure.
New initiativesOptimization of housing rents and other charges, Improvement of productivity in home-visit nursing, Provision of the Life Plan service, Recovery in the operating rate relative to staffing levels, Collaboration with Sugi Holdings on joint facility development and improving the quality of palliative care
Items this document does not state (22)
Net SalesOperating profitOrdinary incomeNet incomeGross Profit MarginOperating profit marginSelling, general and administrative expensesResults for the three months of the current quarterProgress against full-year forecastSelf-assessment against the planSegment resultsKey KPIsNumber of employeesAssumptions Underlying the Business OutlookRisk amount incorporated into the outlookMedium-term management plan targetsFinancial targetsPayout ratioAcquisition of treasury sharesCapital expendituresOrders received and order backlogMarket Size / Share

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

Following the revisions to medical service fees in June, sales per unit declined as pronounced productivity issues emerged during the process of responding to the newly established bundled home-visit nursing care fee. Utilization also declined following a review of housing rents and other charges, making it necessary to examine the impact on full-year results. The company stated that it was difficult to calculate a reasonable earnings forecast immediately after the new system took effect.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
FAQ on Financial Results for the Second Quarter of the Fiscal Year Ending December 2026 | Japan Hospice Holdings Inc. (7061) timely disclosure | Komori